alpha glucosidase inhibiting chaperones (NCATS/NHGRI)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha glucosidase inhibiting chaperones (NCATS/NHGRI)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Glycogen Storage Disease Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Center For Advancing Translational Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Center For Advancing Translational SciencesNational Human Genome Research Institute
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Glycogen Storage Disease Type II

Other Information

ATC CodeN/A
Related LinksN/A